Seminars in Oncology
Volume 30, Issue 5 , Pages 649-658, October 2003

Immunotherapy for prostate cancer☆

  • Lawrence Fong

      Affiliations

    • Departments of Medicine, and Microbiology/Immunology, University of California, San Francisco, San Francisco, CA, USA
    • Corresponding Author InformationAddress reprint requests to Lawrence Fong, MD, UCSF Comprehensive Cancer Center, 1600 Divisadero St, Box 1711, San Francisco, CA 94143-1711, USA
    • ,
  • Eric J Small

      Affiliations

    • Departments of Medicine and Urology, University of California, San Francisco, San Francisco, CA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by by CapCure and NIH NCI Grant No. K23 CA82584-01.

PII: S0093-7754(03)00350-6

doi:10.1016/S0093-7754(03)00350-6

Seminars in Oncology
Volume 30, Issue 5 , Pages 649-658, October 2003

Article Tools

* Image Usage & Resolution